Paris - Delayed Quote EUR
Carmat SA (ALCAR.PA)
0.8052
+0.0002
+(0.02%)
As of 2:05:37 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,000
7,000
2,848
372
2,338
Cost of Revenue
30,559
30,559
33,819
28,819
42,848
Gross Profit
-23,559
-23,559
-30,971
-28,447
-40,510
Operating Expense
16,549
16,549
10,004
15,689
7,618
Operating Income
-40,108
-40,108
-40,975
-44,136
-48,128
Net Non Operating Interest Income Expense
-3,171
-3,171
-3,048
-3,820
-3,316
Pretax Income
-53,053
-53,053
-55,566
-55,742
-63,737
Tax Provision
-1,658
-1,658
-1,698
-2,062
-1,863
Net Income Common Stockholders
-51,395
-51,395
-53,869
-53,681
-61,873
Diluted NI Available to Com Stockholders
-51,395
-51,395
-53,869
-53,681
-61,873
Basic EPS
-1.15
--
-2.09
-2.28
-3.81
Diluted EPS
-1.15
--
-2.09
-2.28
-3.81
Basic Average Shares
44,691.3040
--
25,815.6250
23,595.3400
16,235.4620
Diluted Average Shares
44,691.3040
--
25,815.6250
23,595.3400
16,235.4620
Total Operating Income as Reported
-49,241
-49,241
-52,519
-51,922
-60,408
Total Expenses
47,108
47,108
43,823
44,508
50,466
Net Income from Continuing & Discontinued Operation
-51,395
-51,395
-53,869
-53,681
-61,873
Normalized Income
-41,946.7985
-41,946.7985
-42,702.9700
-46,209.0198
-49,940.2889
Interest Income
121
121
373
--
--
Interest Expense
3,292
3,292
3,421
3,820
3,316
Net Interest Income
-3,171
-3,171
-3,048
-3,820
-3,316
EBIT
-49,761
-49,761
-52,145
-51,922
-60,421
EBITDA
-49,523
-49,523
-46,250
-53,406
-51,983
Reconciled Cost of Revenue
30,559
30,559
33,819
28,819
42,848
Reconciled Depreciation
238
238
5,895
-1,484
8,438
Net Income from Continuing Operation Net Minority Interest
-51,395
-51,395
-53,869
-53,681
-61,873
Total Unusual Items Excluding Goodwill
-9,753
-9,753
-11,518
-7,759
-12,292
Total Unusual Items
-9,753
-9,753
-11,518
-7,759
-12,292
Normalized EBITDA
-39,770
-39,770
-34,732
-45,647
-39,691
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-304.7985
-304.7985
-351.9700
-287.0198
-359.2889
12/31/2021 - 7/13/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALSGD.PA SpineGuard SA
0.1092
+0.18%
ALMKT.PA Mauna Kea Technologies SA
0.0958
-2.94%
XVIVO.ST Xvivo Perfusion AB (publ)
313.00
-0.82%
NEOLA.ST Neola Medical AB (publ)
2.4000
+0.42%
USAQ QHSLab, Inc.
0.2000
0.00%
AFME.PA Affluent Medical SA
1.3100
0.00%
VIRO.CO ViroGates A/S
6.70
+3.08%
EPIS-B.ST Episurf Medical AB (publ)
0.1144
+3.44%
MHC.L MyHealthChecked PLC
14.00
0.00%
PHI1.DE Koninklijke Philips N.V.
21.89
-2.97%